Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Respiratory therapeutics Market Research Reports

Titlepublishedprice

Respiratory Depression-Pipeline Insights, 2017

By Delve Insight
"...... re-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA......"
01-Jan-2017$1250

Respiratory Distress Syndrome-Pipeline Insights, 2017

By Delve Insight
"...... g Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent a......"
01-Jan-2017$1250

Lower Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... er Respiratory Tract Infections Report is to understand the market and pipeline status of the drugs around the Lower Respiratory Tract Infections to explore the generic development opportunities, licensing opportunities and to gain competitive advant......"
01-Jan-2017$2000

Upper Respiratory Tract Infections -API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection-Pipeline Insights, 2017

By Delve Insight
"...... ers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including techn......"
01-Jan-2017$1250

Bronchiectasis-Pipeline Insights, 2017

By Delve Insight
"...... , Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations de......"
01-Jan-2017$1250

Bronchiolitis-Pipeline Insights, 2017

By Delve Insight
"...... Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations deta......"
01-Jan-2017$1250

Bronchiolitis Obliterans-Pipeline Insights, 2017

By Delve Insight
"...... y, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA &......"
01-Jan-2017$1250

Bronchitis-Pipeline Insights, 2017

By Delve Insight
"...... I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. D......"
01-Jan-2017$1250

Acute Respiratory Distress Syndrome - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... pain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Acute Respiratory Distress Syndrome forecasted market share for ten years to 2023 segmented by seven major markets. In addition, t......"
01-Jan-2017$4950

Avail upto 50% Discount on below Publisher Reports.